Navigation Links
New Data Demonstrates Abbott's Investigational MitraClip(R) System Has Potential to be a Valuable Treatment Option for Patients With Mitral Regurgitation, the Most Common Heart Valve Condition
Date:3/14/2010

such as hypertension and congestive heart failure, than the average surgical patient as defined by the 2008 Society for Thoracic Surgeons (STS) Database. Patients were selected for treatment with the MitraClip device if they met the criteria for surgical intervention from the 1998/2006 American College of Cardiology (ACC)/ American Heart Association (AHA) Joint Task Force Recommendations regarding therapy for valvular heart disease. Patients had at least moderate-to-severe functional or degenerative mitral regurgitation and were either symptomatic or asymptomatic with evidence of compromised left ventricular function, atrial fibrillation or pulmonary hypertension. The echocardiography core laboratory at the University of California, San Francisco (UCSF) reviewed the trial's echocardiograms based on the American Society of Echocardiography (ASE) criteria for assessment of MR and left ventricular function.

About Mitral Regurgitation

MR is the most common type of heart valve insufficiency in the United States and Europe, affecting millions of people worldwide. MR affects more than 8 million people in the U.S. and Europe. There are more than 600,000 new diagnoses of significant MR each year in the U.S. and Europe; however, only about 20 percent of these patients undergo surgery each year. While many patients are either higher-risk surgical patients or not sick enough for surgery, approximat
'/>"/>

SOURCE Abbott
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. New Study Demonstrates Safety of Balloon Sinuplasty(TM) Technology in Pediatric Patients Suffering From Chronic Sinusitis
2. Tobiras Next-Generation Once-Daily CCR5 Receptor Antagonist Demonstrates Efficacy, Safety and Tolerability in Treatment-Experienced Patients With HIV
3. Transgenomic Demonstrates Very High Sensitivity Detection of Tumor-Associated KRAS Mutations in Matched Plasma Samples Using COLD-PCR
4. AsepticSure(TM) Hospital Sterilization System Demonstrates Total Eradication of Super Bugs
5. Phase 2 Trial of LX4211 Demonstrates Significant and Rapid Improvements in Multiple Parameters in Type 2 Diabetic Patients
6. Study Demonstrates Value of HPV Screening to Prevent Invasive Cervical Cancer
7. ERT Demonstrates Patient Safety Expertise in Clinical Trials with New Knowledge Series of Papers
8. ANA598 Demonstrates Positive 4-Week Results at 200 mg BID
9. Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 Studies
10. Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection
11. European Lung Cancer Screening Trial Demonstrates New Inexpensive Strategy for Improving Accuracy of Diagnosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)... , April 28, 2015 ANI Pharmaceuticals, ... Company plans to release its first quarter 2015 financial ... of the U.S. financial markets. The earnings press release ... the Company,s website, www.anipharmaceuticals.com . ... Officer, and Charlotte C. Arnold , Vice President ...
(Date:4/28/2015)... CARLOS, Calif. , April 28, 2015  Rosa ... expertise in drug-disease modeling and simulation, today announced its ... in the exciting field of Quantitative Systems Pharmacology (QSP). ... in pharmaceutical drug development.  ... Rosa,s ...
(Date:4/28/2015)...  Boston Scientific Corporation (NYSE: BSX ) ... quarter ended March 31, 2015, compared to the ... to $1.800 billion.  This represents 6 percent operational ... and flat revenue on a reported basis, all ... achieved adjusted earnings per share of $0.21 for ...
Breaking Medicine Technology:ANI Pharmaceuticals Schedules Conference Call for First Quarter 2015 Financial Results 2Rosa & Co. is the Lead Partner for the Quantitative Systems Pharmacology (QSP) Congress in Basel, Switzerland and Will Present the Keynote Address 2Rosa & Co. is the Lead Partner for the Quantitative Systems Pharmacology (QSP) Congress in Basel, Switzerland and Will Present the Keynote Address 3Boston Scientific Announces Results for First Quarter 2015 2Boston Scientific Announces Results for First Quarter 2015 3Boston Scientific Announces Results for First Quarter 2015 4Boston Scientific Announces Results for First Quarter 2015 5Boston Scientific Announces Results for First Quarter 2015 6Boston Scientific Announces Results for First Quarter 2015 7Boston Scientific Announces Results for First Quarter 2015 8Boston Scientific Announces Results for First Quarter 2015 9Boston Scientific Announces Results for First Quarter 2015 10Boston Scientific Announces Results for First Quarter 2015 11Boston Scientific Announces Results for First Quarter 2015 12Boston Scientific Announces Results for First Quarter 2015 13Boston Scientific Announces Results for First Quarter 2015 14Boston Scientific Announces Results for First Quarter 2015 15Boston Scientific Announces Results for First Quarter 2015 16Boston Scientific Announces Results for First Quarter 2015 17Boston Scientific Announces Results for First Quarter 2015 18Boston Scientific Announces Results for First Quarter 2015 19Boston Scientific Announces Results for First Quarter 2015 20Boston Scientific Announces Results for First Quarter 2015 21Boston Scientific Announces Results for First Quarter 2015 22Boston Scientific Announces Results for First Quarter 2015 23Boston Scientific Announces Results for First Quarter 2015 24Boston Scientific Announces Results for First Quarter 2015 25
... AT&T * today announced that the Arkansas Department ... mobile flu clinic solution to help the agency more efficiently ... to extend the use of the application to other year-round ... As an important part of its mission to ...
... 2011 Inhibitex, Inc. (Nasdaq: INHX ) today ... shares of its common stock, at a purchase price of ... The net proceeds to Inhibitex from the sale of the ... are expected to be approximately $44 million.  Inhibitex has granted ...
Cached Medicine Technology:Arkansas Department of Health Chooses AT&T to Streamline Delivery of Public Health Programs 2Arkansas Department of Health Chooses AT&T to Streamline Delivery of Public Health Programs 3Arkansas Department of Health Chooses AT&T to Streamline Delivery of Public Health Programs 4Inhibitex Prices $47 Million Public Offering 2Inhibitex Prices $47 Million Public Offering 3
(Date:4/28/2015)... LI, New York (PRWEB) April 28, 2015 ... Therapy in Commack. 2015 will be the third year that ... attention for the entire week. Hands On is offering some ... be offered. "What better time of the year could there ... Hands On. "All women deserve pampering and this is a ...
(Date:4/28/2015)... April 28, 2015 The buyer power ... out of 5, indicating a medium level of buyer ... and suppliers have equal power during negotiations. One factor ... than purchasing a health insurance policy from an insurance ... Humana), buyers can choose to self-fund their own policy ...
(Date:4/28/2015)... 28, 2015 Dead or damaged trees can ... property. In many cases, tree removal by a skilled team ... eliminate the threat. , In their latest article ... removal available to property owners today. Each method requires skill ... job well done. , The article states that, “Tree removal ...
(Date:4/28/2015)... Washington, DC (PRWEB) April 28, 2015 ... for Medicare-Medicaid dual eligibles reached 2.2 million in ... Services, Inc.’s (AIS) new Medicare-Medicaid Dual Eligibles ... all programs and plans serving the dual-eligible community. ... Dual Eligibles Database began tracking initiatives in January, ...
(Date:4/28/2015)... (PRWEB) April 28, 2015 “ Gwee ... monthly Tech Report, which features the latest and coolest ... expert and special reporter for NewsWatch, conducted the review ... innovative iPad case. , As much as everyone loves ... the screen. Aside from looking at them, it's even ...
Breaking Medicine News(10 mins):Health News:Commack Massage Therapy and Wellness Day Spa Dedicates Time To Celebrate Women 2Health News:New Data for Group Health Insurance Procurement Category Market Research Report from IBISWorld 2Health News:New Data for Group Health Insurance Procurement Category Market Research Report from IBISWorld 3Health News:New Data for Group Health Insurance Procurement Category Market Research Report from IBISWorld 4Health News:Tree Removal Methods and Services Discussed in Recent Article by Precision Tree Services 2Health News:Enrollment in Duals Programs Increases 14%, New AIS Database Finds 2Health News:The Most Innovative iPad Case was Featured on NewsWatch Television 2
... SILVER SPRING, Md., July 6 The Obesity Society, the ... obesity, is pleased to announce the selection of Francesca M. ... Ms. Dea comes to The Obesity Society with an ... and media relations. , , According to Robert Kushner, ...
... famotidine effective at curtailing ulcers , MONDAY, July 6 (HealthDay ... in people taking low-dose aspirin, often to reduce the risk ... phase III trial included 404 patients taking 75 milligrams to ... to take either 20 milligrams of famotidine or a placebo ...
... in those with advanced chronic heart failure, have an ... to new research from researchers at the University of ... in the European Heart Journal , also suggest ... risk of death in heart failure patients, contradicting previous ...
... 6 SCAN Health Plan of Arizona has announced that ... Studios today. This partnership allows SCAN Health Plan to regularly ... and weekend shows. , , SCAN also will serve ... Gila River Casino Club 55+. This initiative is part of ...
... future of organ transplantation could include microscopic beads that ... new organ, Medical College of Georgia researchers say. ... at the MCG Center for Molecular Chaperone/Radiobiology and Cancer ... with skin grafts. The degradable microparticles deliver the ...
... Blood Types - Patients Need YOU , , NEW ... York Blood Center (NYBC) and its divisions in Manhattan, Long ... call upon the community to please give blood this month. ... of all blood types and ethnicities are encouraged to donate ...
Cached Medicine News:Health News:The Obesity Society Selects Executive Vice President 2Health News:Drug Limits Stomach Trouble in Patients Taking Low-Dose Aspirin 2Health News:Atrial fibrillation linked to increased hospitalization in heart failure patients 2Health News:Arizona's AM 1230 KOY to be Broadcast from SCAN Health Plan Studios 2Health News:Microscopic 'beads' could help create 'designer' immune cells that ignore transplanted organs 2Health News:Who Says Negatives Can't Be Positive? 2Health News:Who Says Negatives Can't Be Positive? 3
Ultraview 1700 Central Monitor...
The Hypervisor VI is a solution for telemetry, LAN and wireless LAN networking. It includes bi-directional communication with Mindray bedside patient monitors and can store waveforms and numeric info...
DS 7600 Central Station...
... The MedSystem III DLE (Drug List ... dimension to drug infusion technology. The instrument ... features and clinical versatility in an unparalleled ... Calculation, the MedSystem III Infusion System simplifies ...
Medicine Products: